adamantane has been researched along with Liver Dysfunction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furihata, K; Inoue, K; Ito, T; Kaneko, Y; Katashima, M; Miyatake, D; Nishimura, T; Oda, K; Sakaki, M; Shibata, T; Toyoshima, J; Uchida, N; Urae, A | 1 |
| Ali, S; Fonseca, V | 1 |
| Campestrini, J; Dilzer, SC; Dole, WP; He, YL; Howard, D; Lasseter, KC; Ligueros-Saylan, M; Sabo, R; Wang, Y | 1 |
| Belshe, R; Berry, C; De Grazia, F; Lin, A; Milazzo, J; Tomlinsin, D; Wells, S; Wills, RJ | 1 |
1 review(s) available for adamantane and Liver Dysfunction
| Article | Year |
|---|---|
Saxagliptin overview: special focus on safety and adverse effects.
Topics: Adamantane; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Drug Dosage Calculations; Drug Interactions; Humans; Kidney Diseases; Liver Diseases; Patient Selection; Risk Assessment; Risk Factors; Treatment Outcome | 2013 |
1 trial(s) available for adamantane and Liver Dysfunction
| Article | Year |
|---|---|
The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin.
Topics: Adamantane; Adult; Analysis of Variance; Area Under Curve; Chronic Disease; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Hypoglycemic Agents; Liver Diseases; Male; Middle Aged; Nitriles; Pyrrolidines; Vildagliptin | 2007 |
2 other study(ies) available for adamantane and Liver Dysfunction
| Article | Year |
|---|---|
Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects With Normal and Impaired Hepatic Function.
Topics: Adamantane; Administration, Oral; Aged; Area Under Curve; Asian People; Female; Humans; Janus Kinase Inhibitors; Liver Diseases; Liver Function Tests; Male; Middle Aged; Niacinamide; Severity of Illness Index | 2020 |
Pharmacokinetics of rimantadine hydrochloride in patients with chronic liver disease.
Topics: Adamantane; Adult; Aged; Chronic Disease; Female; Half-Life; Humans; Liver Diseases; Male; Middle Aged; Rimantadine | 1987 |